Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

His family history included premature coronary artery disease and heart ... cardiomyopathy. Echocardiography showed not only thickened ventricular walls but also biatrial enlargement with normal ...

Differentiation of HCM from other cardiomyopathies Hypertensive heart disease is characterized by symmetrical increase in left ventricular (LV) wall thickness with normal LV dimension. In athlete ...

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and ...

Echocardiography reveals left ventricular dimensions within the normal range ... and hypertrophic cardiomyopathy, were considered part of the spectrum of conditions defined as heart failure ...

If you are one of those who pop painkillers all too often, then you might be raising your risk of heart attack and heart disease. Prolonged use means these can interfere with the heart’s normal ...

Camzyos (mavacamten) is a prescription drug used to treat a heart condition called obstructive hypertrophic cardiomyopathy (HCM). Camzyos can cause side effects that range from mild to serious.

Read on to learn more about resting heart rate including normal resting heart rates based on age, target heart rate zones during activity and red flags to consider, plus causes of an elevated ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

Thanks to quick and effective CPR with a defibrillator, coaches were able to save Spencer Davis’ life. Now the 16-year-old ...